Cambridge Healthtech Institute’s Third Annual

PCR for Molecular Medicine

From Assay to FDA: Preparing PCR for Personalized Medicine

March 7-9, 2016 | Moscone North Convention Center | San Francisco, CA
Part of the 23rd International Molecular Medicine Tri-Conference

 

Polymerase chain reaction (PCR) has become increasingly cost effective, sensitive, and precise. With emphasis on personalized medicine on the rise, the need for inexpensive, reliable diagnostics will grow. Today, advances in PCR have sparked innovation, expanded research capabilities, and made the technology more clinically useful than ever. Cambridge Healthtech Institute’s Third Anunal PCR for Molecular Medicine will emphasize integrated approaches for PCR, from traditional to digital, as well as next-generation sequencing. PCR for Molecular Medicine will provide a comprehensive look at PCR from assay development to FDA approval as well as insight into advanced techniques and tools for effective disease diagnosis. 

Who should attend: VPs, Directors, Managers, CEOs, CSOs, Professors and Scientists from Large Pharma, Biotechs and Academia working in fields such as Diagnostics, Business Development, R&D, Chemistry, Clinical Research, Personalized Healthcare, Process Development, and Oncology.

Topics will include, but are not limited to: 

  • Technologies to drive personalized medicine
  • Longitudinal studies
  • Increasing sensitivity and specificity of assays
  • New techniques for library preparation
  • Comparison and standardization of methods
  • Optimizing input for single cell analysis
  • FDA guidance and rulings
  • Case studies on getting FDA approval
  • Translating from technology to clinically useful data
  • Clinical case studies

If you would like to submit a proposal to give a presentation at this meeting, please click here.

The deadline for submission is August 7, 2015. 

All proposals are subject to review by the Scientific Advisory Committee to ensure the highest quality of the conference program. Please note that due to limited speaking slots, preference is given to pharmaceutical and biotech companies, regulators and those from academia. Additionally, vendors/consultants who provide products and services to these biopharmaceutical companies are offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships. 

For more details on the conference, please contact:
Samantha Drinkwater
Conference Producer
Cambridge Healthtech Institute
T: (+1) 781-972-5461
E: sdrinkwater@healthtech.com 

For partnering and sponsorship information, please contact:
Jon Stroup (Companies A-K)
Senior Manager, Business Development
Cambridge Healthtech Institute
T: (+1) 781-972-5483
E: jstroup@healthtech.com 

Joseph Vacca (Companies L-Z)
Associate Director, Business Development
Cambridge Healthtech Institute
T: (+1) 781.972.5431
E: jvacca@healthtech.com 

Premier Sponsors:   

Elsevier    

Jackson Laboratory - small logo  

 NanoString2    

 Precision for Medicine 

SeraCare 

Silicon Biosystems 

Thomson Reuters-Large